Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Share:
More In Business
OpenAI partners with Walmart to let users buy products in ChatGPT
OpenAI is partnering with Walmart to allow shoppers to make purchases directly within ChatGPT.
News organizations reject new Pentagon reporting rules
Fox News, the former employer of Defense Secretary Pete Hegseth, has joined a near-unanimous outpouring of news organizations rejecting new rules for journalists based in the Pentagon.
Wall Street Whiplash: Bill Mann Breaks Down Last Friday's Market Mayhem
Motley Fool’s Bill Mann unpacks October 10th's market chaos, what triggered it, and where smart investors should look next. Don’t miss his expert insight!
Clear Vision: Warby Parker Co-CEO on $75M Eye Care Push
Warby Parker Co-CEO Neil Blumenthal joins us to talk World Sight Day and Bloomberg Philanthropies’ $75M initiative to tackle global vision impairment.
Pope urges news agencies to stand as bulwark against lies, manipulation and post-truths
Pope Leo XIV has encouraged international news agencies to stand firm as a bulwark against the “ancient art of lying” and manipulation.
